Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals

  1. Negredo, E.
  2. Estrada, V.
  3. Domingo, P.
  4. Gutierrez, M.D.M.
  5. Mateo, G.M.
  6. Puig, J.
  7. Bonjoch, A.
  8. Ornelas, A.
  9. Echeverriá, P.
  10. Estany, C.
  11. Toro, J.
  12. Clotet, B.
Revue:
Journal of Antimicrobial Chemotherapy

ISSN: 1460-2091,  0305-7453

Année de publication: 2017

Volumen: 72

Número: 3

Pages: 844-849

Type: Article

DOI: 10.1093/JAC/DKW504 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus